Biotechnology council announces strategic alliance
The Massachusetts Biotechnology Council (MBC) has announced an alliance with Fisher Scientific, part of Thermo Fisher Scientific. As a primary supplier, Fisher Scientific will support the product and supply chain service needs of Massachusetts biotechnology companies and will help to accelerate the industry's growth.
The Massachusetts Biotechnology Council (MBC) has announced an alliance with Fisher Scientific, part of Thermo Fisher Scientific. As a primary supplier, Fisher Scientific will support the product and supply chain service needs of Massachusetts biotechnology companies and will help to accelerate the industry's growth. This solutions-based alliance will give MBC member companies access to the array of technologies offered by Fisher Scientific including scientific, safety and laboratory products.
"We believe that Fisher Scientifics' portfolio of technologies, lab supply products and services will provide the quality and savings we demand for our members," said Robert K. Coughlin, MBC president and CEO. "This partnership will help us fulfil our mission of fostering an environment that enables every biotechnology company to reach its full potential."
Further information about Fisher Scientific is available on-line at www.fishersci.com
Assessing Safety of Medications During Pregnancy and Breastfeeding with LC–MS/MS
Published: April 8th 2025 | Updated: April 8th 2025Researchers conducted a study on medications used in psychiatry and neurology during the perinatal period, assessing how antiepileptic drugs (AEDs) affect placental functions, including transport mechanisms, nutrient transport, and trophoblast differentiation. Several quantitative methods, such as those for antianxiety and hypnotic drugs, were established to evaluate the safety of pharmacotherapy during breastfeeding using liquid chromatography-tandem mass spectrometry (LC–MS/MS).
